Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSteppe Cement Regulatory News (STCM)

Share Price Information for Steppe Cement (STCM)

Share Price is delayed by 15 minutes
Get Live Data
20.00    0.00 (0.00%)
Bid:
19.00
Ask:
21.00
Spread: 2.00 (10.526%)
Market Cap: £43.80m
STCM Live PriceLast checked at - London Stock Exchange

Intraday Steppe Cement Share Chart

Market Update for 3Q 2012

12 Oct 2012 07:00

RNS Number : 5651O
Steppe Cement Limited
12 October 2012
 



Steppe Cement Ltd

12 October 2012

 

Market Update for the Third Quarter ended 30 September 2012

 

Third quarter 2012 revenue of KZT 7,233 million was 28% higher than the corresponding quarter in 2011. For the 9 months ended 30 September 2012, Steppe Cement Ltd ("Steppe Cement" or "the Company") recorded revenue of KZT 14,961 million compared with KZT 11,933 million in the corresponding 9 month period in 2011, representing a 25% improvement.

 

Sales volume of 518,433 tonnes was achieved during the third quarter, a 16% increase over the third quarter of 2011. For the first 9 months of 2012, the sales volume increased by 8% to 1,134,271 tonnes from 1,048,122 tonnes in the corresponding 9 month period in 2011.

 

Average price (ex-VAT) for delivered cement was 16% higher at KZT 13,190 per tonne in the first 9 months this year compared with KZT 11,385 per tonne in the corresponding period in 2011. For the 9 months to September 2012, the ex-factory price stood at KZT 11,119 per tonne representing USD74 per tonne based on current exchange rates. 

 

For the first 9 months of 2012, the cement market in Kazakhstan increased by 13% compared to the corresponding period in 2011. Steppe Cement has therefore revised its estimate of the cement market consumption for 2012 from 6.8 million tonnes to 7.0 million tonnes. Imports into Kazakhstan declined to 13% from 15% in the corresponding 9-month period in 2011. Steppe Cement's market share at 20% is similar compared with the corresponding 9-month period in 2011.

 

Line 5 update

 

In the first 9 months of 2012, Steppe Cement has spent approximately USD 6 million towards the completion of line 5 out of its cash flow. The Company continues to explore different options to fund the remaining USD 34 million including debt, internally generated cash flow and equity.

 

Central Asia Cement, a fully owned subsidiary of the Company, has registered two bonds with 5 and 6 year maturities with the Committee for the Control and Supervision of the Financial Market and Financial Organisations of the National Bank of the Republic of Kazakhstan (FMSC). We are proceeding to obtain a listing for these in the Kazakhstan Stock Exchange (KASE). The decision on final bond placement and its amount will depend on the yield that can be obtained. In parallel we have obtained preliminary terms from multilateral organizations.

 

The board intends to choose among the different sources of financing before the end of 2012 with a completion target for the project in the last quarter of 2013.

 

 

The Company's Nominated Adviser is RFC Ambrian Limited.

Contact: Stephen Allen or Trinity McIntyre, ph: +61 8 9480 2500

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCBKBDNQBDKBKD
Date   Source Headline
13th Apr 20238:00 amRNSMarket update for the quarter ended 31 March 2023
11th Jan 20237:00 amRNSTrading Statement
17th Nov 20224:41 pmRNSSecond Price Monitoring Extn
17th Nov 20224:35 pmRNSPrice Monitoring Extension
10th Nov 20227:00 amRNSDividend Declaration
12th Oct 20227:00 amRNSPurchase of Shares by Family of Director
12th Oct 20227:00 amRNSPurchase of Shares by Substantial Shareholder
7th Oct 20227:00 amRNS3rd Quarter Market Update
26th Sep 20227:00 amRNSHalf-year Report
14th Jul 20227:00 amRNSChange in Holding(s) in Company
14th Jul 20227:00 amRNSResult of AGM
12th Jul 20227:00 amRNSMarket Update - First half of 2022
5th Jul 20227:00 amRNSNotice of AGM and Submissions of Questions
13th Jun 20227:00 amRNSFY2021 Accounts
13th Jun 20227:00 amRNSDividend Proposal and Nomination of Director
13th Jun 20227:00 amRNSNotice of AGM and 2021 Annual Report publication
20th Apr 202210:52 amRNSPurchase of Shares by Substantial Shareholder
13th Apr 20227:00 amRNSMarket Update for quarter ended 31 March 2022
4th Mar 20227:00 amRNSChange in Interests
13th Jan 20227:00 amRNSTrading Update for 2021
12th Nov 20217:00 amRNSStatement re Interim Dividend Policy
8th Oct 20217:00 amRNSSteppe Cement Ltd - 3rd Quarter Results
17th Sep 20217:00 amRNSInterim Results and General Market Update
8th Jul 20217:00 amRNSFinal Dividend FY2020
8th Jul 20217:00 amRNSAGM Results
7th Jul 20217:00 amRNSMarket update for the first half of 2021
7th Jun 20218:01 amRNSFinal Results and Accounts 2020
7th Jun 20218:00 amRNSNotice of AGM + Annual Report 2020
13th Apr 20217:00 amRNSMarket Update for Quarter ended 31 March 2021
19th Feb 20217:00 amRNSHolding(s) in Company
11th Jan 20217:00 amRNSPreliminary Update for the Year ended 31 Dec 2020
29th Oct 20208:00 amRNSDeclaration of Interim Dividend
9th Oct 20207:00 amRNSMarket Update for 3rd Quarter ended 30 Sept 2020
5th Oct 20208:36 amRNSHolding(s) in Company
1st Oct 20207:00 amRNSAppointment of Alternate Directors
21st Sep 20207:00 amRNSHolding(s) in Company
16th Sep 20207:00 amRNSInterim Results and General Market Update
2nd Sep 20207:00 amRNSPurchase of Shares by Substantial Shareholder
9th Jul 20207:00 amRNSFY2019 Dividend Dates
9th Jul 20207:00 amRNSMarket Update for the First Half of 2020
9th Jul 20207:00 amRNSAGM Results
10th Jun 20207:00 amRNSNotice of AGM
10th Jun 20207:00 amRNSFinal Results and Accounts 2019
14th Apr 20207:00 amRNS1st Quarter Results
10th Jan 20208:19 amRNSPreliminary Results
7th Oct 20197:00 amRNSMarket Update for the 3rd Quarter
12th Sep 20197:00 amRNSInterim Results and General Market Update
23rd Jul 20197:00 amRNSHolding(s) in Company
10th Jul 20197:00 amRNSMarket Update for the First Half of 2019
20th Jun 20199:41 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.